These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 15963211

  • 1. Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions.
    Nitti V, Taneja S.
    Int J Clin Pract; 2005 Jul; 59(7):825-30. PubMed ID: 15963211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
    Nik-Ahd F, Lenore Ackerman A, Anger J.
    Curr Urol Rep; 2018 Sep 13; 19(11):94. PubMed ID: 30215140
    [Abstract] [Full Text] [Related]

  • 4. Overactive bladder--a practical approach to evaluation and management.
    Madersbacher H.
    J Med Liban; 2004 Sep 13; 52(4):220-6. PubMed ID: 16432986
    [Abstract] [Full Text] [Related]

  • 5. ["Pathophysiology and treatment of the overactive bladder"].
    Yokoyama O.
    Hinyokika Kiyo; 2005 Sep 13; 51(9):599-601. PubMed ID: 16229372
    [Abstract] [Full Text] [Related]

  • 6. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I.
    Eur Urol; 2009 Apr 13; 55(4):783-91. PubMed ID: 19157689
    [Abstract] [Full Text] [Related]

  • 7. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I.
    BJU Int; 2008 Jun 13; 101(11):1388-95. PubMed ID: 18454794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group.
    BJU Int; 2008 Jun 13; 101(11):1381-7. PubMed ID: 18336602
    [Abstract] [Full Text] [Related]

  • 10. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
    Hung MJ, Ho ES, Shen PS, Sun MJ, Lin AT, Chen GD, Taiwan OAB Club.
    J Urol; 2006 Aug 13; 176(2):636-40. PubMed ID: 16813910
    [Abstract] [Full Text] [Related]

  • 11. The causes and consequences of overactive bladder.
    Miller J, Hoffman E.
    J Womens Health (Larchmt); 2006 Apr 13; 15(3):251-60. PubMed ID: 16620184
    [Abstract] [Full Text] [Related]

  • 12. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
    Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA.
    Int J Clin Pract; 2007 Sep 13; 61(9):1535-46. PubMed ID: 17627768
    [Abstract] [Full Text] [Related]

  • 13. The patient's perspective: redefining end points.
    Palmtag H.
    Urology; 2004 Dec 13; 64(6 Suppl 1):17-20. PubMed ID: 15621223
    [Abstract] [Full Text] [Related]

  • 14. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD, Kaufman JM, Sand PK, Smith N, Andoh M.
    Clin Ther; 2006 Nov 13; 28(11):1935-46. PubMed ID: 17213014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nocturia in adults: draft New Zealand guidelines for its assessment and management in primary care.
    Weatherall M, Arnold T, New Zealand Nocturia Guideline Committee.
    N Z Med J; 2006 May 19; 119(1234):U1976. PubMed ID: 16718287
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.
    Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O.
    Urology; 2006 Aug 19; 68(2):318-23. PubMed ID: 16904444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.